Key Accounts Specialist-Hospital Tender Business(Pharma sales) Client Of IKYA HUMAN CAPITALS

Experience: 2 - 7 Years
Location: Bengaluru/Bangalore, Chennai, Delhi/NCR, Erode, Hyderabad / Secunderabad, Kolkata, Mumbai, Navi Mumbai, Pune
Education: UG - B.Pharma - Pharmacy,B.Sc - Any Specialization
PG - Any PG Course - Any Specialization,Post Graduation Not Required
Industry Type: Pharma/ Biotech/Clinical Research
Role: Institutional Sales/BD Mgr
Functional Area: Sales, BD

Desired Candidate Profile

• Candidate Should Having minimum Two Years Experience in Hospital Tender Business
• Candidate Shoulbe Science Graduate B.Sc or B.Pharmacy
• Position Open for All metros and major Cities in India

Job Description

• Covere govt. institutions in the city and participating in the tender process
• To visit government institutions & Corporate Hospitals generate Business for RC/ tender product.
• Handle Institutional L.P. and Tender Business of Central Government, State Government and Autonomous Institutes
  

Company Profile

Leading MNC Pharmaceutical Company

Company Name: Client Of IKYA HUMAN CAPITALS

Executive Name: Krishna V

Email Address: krishnav@ikyaglobal.com

Executive/Assistant Manager- Marketing (Medical Publishing) MEDICCA PRESS

Experience: 2 - 4 Years
Location: Mumbai
Compensation: Rupees 1,75,000 - 2,50,000 Best in the Industry
Education: UG - B.Pharma - Pharmacy,B.Sc - Any Specialization
PG - Any PG Course - Any Specialization, Post Graduation Not Required
Industry Type: Publishing
Role: Sales Exec./Officer
Functional Area: Sales, BD

Desired Candidate Profile

• Graduate with Science, B Pharma. Any profession qualification in sales/marketing is an added advantage.
• 3-4 year marketing/sales experience in bulk pharma sales of scientific promotional materials to pharmaceutical companies or work experience in pharma company(sales/Marketing).

Job Description

Promotion & sales of medical contents like Books, Journals, full text Articles & other medical contents to pharma companies to support their promotional requirements.

Company Profile

We are a medical publisher & leading bulk supplier of medical contents to pharma companies in India. Through lesion & partnership with leading medical publishers around the world, we bring local low cost editions of medical books, Journals & other medical research/reference contents under the sponsorship of from Indian pharma companies.


Company Name: MEDICCA PRESS
Website: http://www.mediccapress.in
Executive Name: Mr. Vivek Singh
Address:
MEDICCA PRESS
411, LAXMI PLAZA, LAXMI INDUESTRIES
NEW LINK ROAD, ANDHERI (W)
MUMBAI,Maharashtra,India 400053
Email Address: vivek@mediccapress.in
Telephone:91-22-26374053

Analyst ( Bsc. & B.Pharm.) INTERNATIONAL TESTING CENTRE

Experience: 0 - 5 Years
Location: Chandigarh, Panchkula
Compensation:Commensurate with ability and Experience
Education:UG - B.Pharma - Pharmacy,B.Sc PG - Post Graduation Not Required
Industry Type:Pharma/ Biotech/Clinical Research
Role:Microbiologist
Functional Area:Healthcare, Medical, R&D
Desired Candidate Profile
The candidate must be a B.Pharm with 6 Months and above experience in the same profile
Job Description
Growth promotion tests and capable of doing the validation of microbial methods and the related aspects and testing of Drugs, food and Pesticides
Company Profile
International Testing Centre (ITC) began its services in 1988 with the prime objective of providing Quality Assurance Services initially in the discipline of drugs & pharmaceuticals.
Company Name:INTERNATIONAL TESTING CENTRE
Website:http://www.itclabs.com
Executive Name:Mr.Anil K Gupta
Address:INTERNATIONAL TESTING CENTRE
86, Industrial Area, Phase – 1,
,,India
Email Address:itc86@yahoo.com
Telephone:91-172-2565825

Agronomists - Three Positions Product Development Mgr

Experience:

4 - 8 Years
Location:

Bengaluru/Bangalore, Chennai, Hyderabad / Secunderabad, Kurnool, Tirupati, Visakhapatnam
Education:

UG - B.Sc - Agriculture PG - Any PG Course - Any Specialization

Industry Type:

Agriculture/Dairy

Role:

Product Development Mgr

Functional Area:

Production, Maintenance, Quality
Posted Date:

14 Mar

Desired Candidate Profile

B Sc - Agriculture, Agri Polytechnic, Life sciences with expereince in any agriculture research institute or large agriculture farm

Job Description
Production of Maize crop with, development activities related to farming and dairy sector, co-ordinate with Isralei experts, harvesting, guiding villagers in farming, analyze crops marketing, pricing, research and study data on Dairy market

Keywords: dairy, milk, farming, maize, analysis, agronomy
Company Profile

Leading MNC into diversified is planning to set up Intergrated Dairy Near Tirupati

Executive Name:

B R Raju
Email Address:

jobs@formulahrc.com
Telephone:

9908899980

Job Available for the Marketing Manager in Bengaluru/Bangalore

Experience:

5 - 10 Years

Location:Bengaluru/Bangalore

Compensation:
Rupees 1,75,000 - 2,25,000

Education:

UG - B.Sc - Agriculture PG - M.Sc - Agriculture

Industry Type:

Agriculture/Dairy

Role:

Mktg Mgr
Functional Area:

Marketing, Advertising, MR, PR
Posted Date:

11 Mar

Desired Candidate Profile
Experience in Agriculture Sector, preferably in coconut industry. Minimum 5-10 Years.

Bsc / Msc (Hort.) / Agri. Diploma / Agri. Engineer

Job Description

He should manage professionally organized coconut breeding station in South India.Experience in Agriculture Sector, preferably in coconut industry. Minimum 5-10 Years.Bsc / Msc (Hort.) / Agri. Diploma / Agri. Engineer

Keywords: Marketing Manager

Company Profile

Hybrid Coconut Breeding Stations and Agricultural Farming Activities, located in different parts of South India.Located at Brigade Road
Contact Details
Company Name:

Email Address:

esther@growellhr.com

Telephone: 09743109368

Agriculture Jobs Alerts

Area Sales Manager

Garihar Bio-Chem Pvt. Ltd.
16, New Shantiniketan, Near Hotel Kunal,
Amrutdham, Panchavati, Nashik, Maharashtra.
Pin 422 003.
Ph 0253 230604
Qualification:- BSc/MSc (Agri), MBA/ Agri Business Management.
Experience:- 2-3 years in a pesticide fertilizer company.


===================================

Regional Sales Manager / Territory Manager

Reputed Multi National Company

Sri Biotech Laboratories India Ltd.
Summary

Experience: 5 - 7 Years

Location: Andhra Pradesh

Compensation: As Per Industry Standards

Education: B.Sc - Agriculture M.Sc Agri.

Industry Type: Fertilizers/ Pesticides

Role: Regional Mgr

Functional Area: Sales, BD

Desired Candidate Profile: BSC(Agri), MSC(Agri)

Job Description: Candidates with 5 - 7 Years Exp in Selling Agro Chemicals/Seeds/Fertilizers,
working for a multinational & national Companies in Andhra Pradesh need apply
Company Profile: Sri Biotech is a globally respected, multidisciplinary, Biotech organization, with its humble beginning in 1994 and taking its pursuit of noble ends to new frontiers.

Company Name:

Sri Biotech Laboratories India Ltd

Executive Name: Srilatha

Email Address: careerssribio@gmail.com
Telephone: 040-32580685
Reference ID: RM(AP)

CAREER IN THE NEW DECADE

Biomedical Informatics is an academic discipline that bridges medicine and information sciences. With the increasing popularity of IT biomedical informatics is making its presence felt in a big way.


"The role of IT in healthcare has become increasingly necessary for modern practices in medicine, efficient and effective management of healthcare and professional health education. Health professionals recognize an urgent need for skilled scientists who are knowledgeable about both medical environment and information technologies," says Dr. Kumud Sarin, head of the department, Biotechnology and Bioinformatics, Bioinformatics Institute of India (BII), Noida.

For the uninitiated, Biomedical Informatics is the combination of theoretical foundations and the current range of applications within contemporary delivery system. It focuses on structure, algorithms and design of efficient logic necessar2y to organize, store and retrieve as well as analyses the data. It is emphasizing to produce knowledge and under-standing about cognition and representation of biomedical knowledge, management of health care systems, clinical decision making, research, design and development of interactive multimedia systems.

Talking about the program offered by BII, Dr. Sarin says: "The purpose of the program in Biomedical Informatics is to prepare students in the applications of computer and information sciences to support and manage and healthcare activities." These can range from those pertaining to the care of the sick to health promotion and disease prevention, medical and health education, health sciences research and management efforts directed towards solutions of problems in the delivery of health care, including resource optimization and cost-effectiveness.

Those interested in making a career out of a degree in Biomedical Informatics would be delighted to know that its applications are rapidly increasing in healthcare and hospital management systems, laboratory automation, quality assurance, financial management and resource allocation, health services and biomedical research. They can also find placements in clinical decision making, treatment monitoring, networking and registration systems, information storage, retrieval and database management systems, simulation and modeling, pattern recognition, biomedical signal and image processing, and health education, research and support systems.

In terms of a professional career, there are several areas within the field where a qualified person can find opportunities. Data management and information analysis apart, there is scope for placement in medical imaging, enabling telemedicine, genomic mapping, systems and software development, and knowledge management. With respect to those with a professional degree in healthcare, job opportunities are available as consultants with management consulting firms, hospital record managers, data analysts, librarians, and positions with the state health departments.

Careers abound in professional companies that offer end-to-end solutions in Biomedical Informatics for medical facilities including setting up systems for IT-enabled clinical practices, medical/diagnostics decision support systems, multimedia healthcare solutions, healthcare content management, clinical knowledge architecture and sharing of healthcare knowledge between different healthcare groups.

The subject also involves the design and statistical analysis of drug trials. Professionals in this field are much in demand at pharmaceutical companies and research labs to work in the areas of modeling, simulations, gene expression control, clinical databases and medical statistics.

The typical starting salary in the sector ranges from Rs. 25,000 to 30,000. Sarin has a positive picture to paint about the future for those pursuing the course. "Our students do immensely well after the completion of the course as we have 100 per cent placement," she adds.

"Indian researchers develops nano version of a cancer drug"

For the first time, a nano version of carboplatin, used in chemotherapy treatment has been developed, wherein unlike the existing molecule, a higher concentration of the drug will attack the cancerous cells and increase the chances of survival of a patient.

A group of five Indian researchers and doctors from the Indian Institute of Technology (IIT), Mumbai; LV Prasad Eye Institute, Apollo Hospitals, Hyderabad; and Tata Memorial Hospital, Mumbai; has researched and developed a nano version of an existing cancer drug, carboplatin. This will reach the cancerous cells at a faster pace, reduce toxicity levels of the chemotherapy drug and further increase chances of survival of the patient. Carboplatin is a chemotherapy drug used against some forms of cancer, especially against cancers affecting brain and central nervous system. If this nano drug is proved successful in human trials, this would be the first nano version of a carboplatin drug in the world.

Dr Debraj Shome, Facial Cancer Expert from Apollo Hospitals, Hyderabad, India, and who heads the five-member research team, said, “We realized that in many cases, large molecule carboplatin drugs could not penetrate and reach the cells in the eyes and the brain. We then thought why not come out with a nano version of this same drug which would be an answer to many shortcomings. Due to the reduced size of the drug it would not be difficult for the molecules to penetrate through the pores of the outer portion of the eye and directly target the cancerous cells.” This was proven through an experiment conducted on rats, one eye of the rat was injected with normal size of carboplatin while the other eye was treated with the nano size of the drug. Chances of toxicity were also shown to be very minimal. “Toxicity levels in the normal carboplatin drug are not an issue as the drug is traditionally been reasonably safe to neural tissue,” added Dr Shome.

The nano version of the drug enters cells upto as much as 75 percent more than the normal generic version of the drug. Moreover, the common problem faced by cancer patients undergoing a chemotherapy treatment was that, an overdose of the existing drug had high chances of killing the healthy cells along with the cancerous ones. As this nano drug will enter more efficiently, lesser amounts of the drug can be used and collateral damage of normal human tissue could be avoided.

This nano drug will mainly target children below the age of two years who are suffering from retinoblastoma (eye cancer) and children and young adults suffering from other round cell tumors. This could be a blessing in disguise for this target group, around 50 percent of whom die not just because of the disease but because of chemotherapy overdose itself. For human trials, the first step was to test 150-200 patients with peri-ocular injections of the normal drug, after which the next step was the animal experiment to develop the nano drug. Subsequently, the step was to test the nano drug on humans. Till date around 5-7 patients with retinoblastoma have already been treated with this nano drug.

While experiments in rats were completed last year, human trials of the nano drug has commenced a few months earlier. This trial has being accepted for publication in the peer-reviewed US-based ophthalmology research journal Investigative Ophthalmology and Visual Sciences.

Nanobiotechnology, has been creating waves in the industry. At present a number of Indian pharma and biotech players are working on applications of nanomedicine in the treatment of a number diseases, cancer being the top most in their list. Biocon and Abraxis BioScience recently launched Abraxane the nanotechnology-based anticancer drug in India for the treatment of breast cancer. Dabur Pharma, a leading manufacturer of anti-cancer drugs, had also launched nanoxel the novel drug delivery system for the widely used anti-cancer drug Paclitaxel. The nanoscale drug delivery system is claimed to be India's first indigenously developed nanotechnology-based chemotherapy agent. Pune-based Tata Chemicals Limited (TCL) is also working on nanotech-based products though they were reluctant to reveal details.

The research team has decided not to hand over the patent to any pharmaceutical company as of now and prefers to work on an independent basis especially in the basic research and development phase. They have filed a patent and typically they would spin off into a different company.

"Genomics promise faster diagnosis of critical infections"

At the plenary session, Innovative Diagnosis, held as part of EmTech India 2010 conference here today, Dr BV Ravikumar, MD, Xcyton Diagnostics, Bangalore talked about the importance of genomics for critical care.

Dr Ravikumar is of the opinion that with the advancement of human genomics, the diagnostics has changed rapidly. He said that critical infection has high mortality rate where a patient dies in 72 to 90 hours. The conventional methods take at last five to six days for the diagnosis. The challenge of diagnosing critical infections are that it should be diagnosed in 24 hours to save the patient’s life.

As infections are often localized, and there would not be any trace of infections in blood or serum, the early diagnosis is difficult. In case of bacterial and fungal infection, using the conventional diagnostics methods take 72 to 96 hours to identify the pathogen. While, diagnosis of viral infection goes up to seven days. Also, the body takes minimum five days to develop the antibodies against the pathogen.

This situation warrants a diagnosis method, which identifies pathogens within 24 hours to save lives. To address this, Xcyton Diagstics has developed a Syndrome Evaluation System, which the company calls as a paradigm shift in this field. In this system, all the genes necessary are incorporated in a chip and analyzed.

The system promises simultaneous detection of pathogens. The advantage of the system is, it takes only seven hours for the detection of critical infections, he said. The system does not not use any fluorescent gels and the end result generated by the system can be read by naked eyes.

He further said that another advantage of the system is that it can be used in district level hospitals. As of now the service has been given to some selected hospitals in the Indian states of Karnataka and Tamil Nadu.

The second edition of the EmTech India 2010, organized by Massachusetts Institute of Technology (MIT) in association with the India edition of Cyber Media's Technology Review, was inaugurated today in Bangalore. The first edition of this premier event happened in New Delhi last year. This is the second edition of EmTech conference being held out side the MIT campus, US.